Global investors led by Societe Generale, Prudential Hong Kong, and Ghisallo Capital Management have acquired a 3% stake in Anthem BioSciences for ₹1,275 crore through open market transactions. According to The Hindu BusinessLine, these investors bought a total of 1.71 crore shares at an average price of ₹744.80 per share. The transaction also attracted participation from several domestic mutual funds, insurance companies, and investment firms, with Nordea Asset Management, Integrated Core Strategies Asia Pte Ltd, and Social Protection Fund among the foreign participants.
The block deal was executed with promoter group entity Aruna Ganesh as the seller, looking to offload up to a 3.05% stake in the company. As reported by The Hindu BusinessLine, the floor price for the sale was set at ₹715 per share, representing a discount of nearly 7% to Wednesday's closing price. Following the transaction, Anthem BioSciences shares were trading flat at ₹798.25 on the NSE. The combined holding of promoters and promoter group entities in Anthem BioSciences declined to 71.63% from 74.68% after the transaction, with promoter Aruna Ganesh selling an equal number of shares and exiting the company.
Among domestic institutional investors, the buyers included SBI Mutual Fund, HDFC MF, Kotak Mahindra MF, UTI MF, Edelweiss MF, Canara Robeco MF, 360 ONE MF, Mahindra Manulife MF, and WhiteOak Capital MF. According to The Hindu BusinessLine, other domestic participants included PI Opportunities AIF V LLP, an affiliate of Premji Invest, Kotak Mahindra Life Insurance Company, Bajaj Life Insurance, and ICICI Prudential Life Insurance. The transaction value stood at ₹1,274.69 crore with the aggregate transaction value reaching the reported ₹1,275 crore.
Following the block deal announcement, Anthem BioSciences shares experienced mixed trading patterns on Friday. As per Upstox News Desk, the stock declined as much as 0.88% to hit an intraday low of ₹791.05 during the noon session on the NSE. However, the stock had opened in the red zone but surged as much as 2.09% to reach the session's peak of ₹814.80 per equity share in early deals. At around 12:24 PM, the scrip was trading 0.46% lower at ₹794.40 per equity share. The stock has gained nearly 1% over the month and 24% on a year-to-date basis, with a total market capitalisation of ₹44,765.56 crore as of June 19, 2026. The stock has touched a 52-week high of ₹873.50 on September 19, 2025, and a year's low of ₹579.15 on February 2, 2026.
